Seq_ID,Species,Phylogenetic lineage,Predicted drug resistance,Rifampicin,Isoniazid,Pyrazinamide,Ethambutol,Moxifloxacin,Amikacin,Cycloserine,Ethionamide,Kanamycin,Streptomycin,Capreomycin,Para-aminosalicylic acid,Clofazimine,Delamanid,Bedaquiline,Linezolid,Median genome coverage,Percentage reads mapped,Quality,Database version
D,Mycobacterium tuberculosis,Lineage 2,Multi-drug resistance predicted (MDR-TB),rpoB_p.His445Asn (Low-level resistant|High),katG_p.Ser315Thr (Resistant|High),pncA_p.Ser104Ile (Resistant|Moderate),embB_p.Met306Val (Resistant|High),gyrA_p.Ala90Val (Resistant only in combination|High),No mechanism identified,No mechanism identified,No mechanism identified* (Susceptible|),No mechanism identified,rrs_n.517C>T (Resistant|Uncertain),No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,No mechanism identified,63,98.45,Pass QC,tbtamr_2022-12-02
